IP Library Granted Patent US 12709657
Granted Patent B2
US 12709657 · App. 17/976,526 · Granted Aug 18, 2026

Curable composition, cured layer using the composition, color filter including the cured layer and display device including the color filter

Inventors: Jonggi Kim (Suwon-si, KR); Yonghee Kang (Suwon-si, KR); Kyunghee Kang (Suwon-si, KR); Jihyeon Yim (Suwon-si, KR); Bumjin Lee (Suwon-si, KR)
Assignee: Samsung SDI Co., Ltd.
C08F136/20C08K3/30C08K5/375C08K9/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12709657
App. No.
17/976,526
Granted
Aug 18, 2026
Kind
B2
Abstract

A curable composition, a cured layer manufactured using the curable composition, a color filter including the cured layer, and a display device including the color filter, the curable composition including a quantum dot surface-modified with a first ligand and a second ligand having a structure different than the first ligand; and a polymerizable compound is provided. The first ligand is a silsesquioxane-based thiol ligand.

Claims (54)

1 . A curable composition, comprising:

a quantum dot surface-modified with a first ligand and a second ligand having a structure different than the first ligand; and

a polymerizable compound,

wherein the first ligand is a silsesquioxane-based thiol ligand and the second ligand is represented by Chemical Formula 2, and

wherein the first ligand and the second ligand are each independently attached directly to a surface of the quantum dot;

wherein, in Chemical Formula 2,

R 1 is a substituted or unsubstituted C1 to C20 alkyl group, a substituted or unsubstituted C3 to C20 cycloalkyl group, a substituted or unsubstituted C6 to C20 aryl group, or a combination thereof,

L 2 and L 3 are each independently a substituted or unsubstituted C1 to C20 alkylene group, a substituted or unsubstituted C3 to C20 cycloalkylene group, a substituted or unsubstituted C6 to C20 arylene group, or a combination thereof, and

n and m are each independently an integer from 0 to 100, and n+m≠0.

2 . The curable composition of claim 1 , wherein

the silsesquioxane-based thiol ligand is a cage silsesquioxane-based thiol ligand.

3 . The curable composition of claim 1 , wherein

the silsesquioxane-based thiol ligand comprises a structural unit represented by Chemical Formula 1:

wherein, in Chemical Formula 1,

L 1 is an ether linking group, a sulfide linking group, a substituted or unsubstituted C1 to C20 alkylene group, a substituted or unsubstituted C3 to C20 cycloalkylene group, a substituted or unsubstituted C6 to C20 arylene group, or a combination thereof.

4 . The curable composition of claim 3 , wherein

the first ligand is represented by Chemical Formula 1-1:

wherein, in Chemical Formula 1-1,

L 1 is an ether linking group, a sulfide linking group, a substituted or unsubstituted C1 to C20 alkylene group, a substituted or unsubstituted C3 to C20 cycloalkylene group, a substituted or unsubstituted C6 to C20 arylene group, or a combination thereof, and

R 2 to R 8 are each independently a substituted or unsubstituted C1 to C20 alkyl group, a substituted or unsubstituted C3 to C20 cycloalkyl group, a substituted or unsubstituted C6 to C20 aryl group, or a combination thereof.

5 . The curable composition of claim 1 , wherein

a content of the first ligand on the surface of the quantum dot is less than or equal to a content of the second ligand.

6 . The curable composition of claim 1 , wherein

a weight ratio of the first ligand to the second ligand on the surface of the quantum dot is about 1:9 to about 5:5.

7 . The curable composition of claim 1 , wherein

the second ligand is a thiol ligand having a structure different from that of the first ligand.

8 . The curable composition of claim 1 , wherein

in Chemical Formula 2, R 1 is a substituted or unsubstituted C6 to C20 aryl group.

9 . The curable composition of claim 1 , wherein

in Chemical Formula 2, R 1 is a substituted or unsubstituted C1 to C20 alkyl group, and L 2 and L 3 are the same.

10 . The curable composition of claim 1 , wherein

in Chemical Formula 2,

R 1 is a substituted or unsubstituted C1 to C20 alkyl group, and

L 2 and L 3 are different from each other.

11 . The curable composition of claim 1 , wherein

the curable composition is a solvent-free curable composition.

12 . The curable composition of claim 11 , wherein

the solvent-free curable composition comprises

about 5 wt % to about 60 wt % of the modified quantum dot surface; and

about 40 wt % to about 95 wt % of the polymerizable compound,

based on the total amount of the solvent-free curable composition.

13 . The curable composition of claim 1 , wherein

the curable composition further comprises a polymerization initiator, a light diffusing agent, a polymerization inhibitor, or a combination thereof.

14 . The curable composition of claim 13 , wherein

the light diffusing agent comprises barium sulfate, calcium carbonate, titanium dioxide, zirconia, or a combination thereof.

15 . The curable composition of claim 1 , wherein

the curable composition further comprises a solvent.

16 . The curable composition of claim 15 , wherein

the curable composition comprises about 1 wt % to about 40 wt % of the modified quantum dot surface; about 1 wt % to about 20 wt % of the polymerizable compound; and about 40 wt % to about 80 wt % of the solvent based on the total weight of the curable composition.

17 . The curable composition of claim 1 , wherein

the curable composition further comprises malonic acid; 3-amino-1,2-propanediol; a silane-based coupling agent; a leveling agent; a fluorine-based surfactant; or a combination thereof.

18 . A cured layer manufactured using the curable composition of claim 1 .

19 . A color filter comprising the cured layer of claim 18 .

20 . A display device comprising the color filter of claim 19 .